Bile duct ligation–induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell–deficient KitW-sh mice

Hepatology

Volumn 65, Issue 6, 2017, Pages 1991-2004

  Hargrove, Laura ^b   Kennedy, Lindsey ^a,c   Demieville, Jennifer ^a   Jones, Hannah ^b   Meng, Fanyin ^a,b,c   DeMorrow, Sharon ^a,c   Karstens, Walker ^b   Madeka, Taronish ^b   Greene, John ^b   Francis, Heather ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; CYTOKERATIN 19; HISTAMINE; HISTAMINE RECEPTOR; HISTIDINE DECARBOXYLASE; HYDROXYPROLINE; KI 67 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN C; VON WILLEBRAND FACTOR; VASCULOTROPIN A;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT DISEASE; BILE DUCT LIGATION; CELL ACTIVATION; CELL PROLIFERATION; CHOLANGIOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME IMMUNOASSAY; HEPATIC STELLATE CELL; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTRAHEPATIC BILE DUCT; LIVER FIBROSIS; LIVER INJURY; MALE; MAST CELL; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; SUPERNATANT; ANIMAL; APOPTOSIS; BILIARY TRACT DISEASE; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DISEASE MODEL; INJURIES; KNOCKOUT MOUSE; LIGATION; LIVER; LIVER CIRRHOSIS; METABOLISM; NEEDLE BIOPSY; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZATION; REFERENCE VALUE; SURGERY; TRANSPLANTATION;

ANIMALS; APOPTOSIS; BILE DUCTS, INTRAHEPATIC; BILIARY TRACT DISEASES; BIOPSY, NEEDLE; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HEPATIC STELLATE CELLS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LIGATION; LIVER; LIVER CIRRHOSIS; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RANDOM ALLOCATION; REFERENCE VALUES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 85018938765     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.29079     Document Type: Article

References (47)

1. Alpini G, Prall RT, LaRusso NF. The pathobiology of biliary epithelia. In: I.M. Arias, J.L. Boyer, F.V. Chisari, N. Fausto, W. Jakoby, D. Schachter, D.A. Shafritz, eds, The Liver; Biology & Pathobiology, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:421-435.
2. Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology 2013;145:521-536.
3. Timmer MR, Beuers U, Fockens P, Ponsioen CY, Rauws EA, Wang KK, Krishnadath KK. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma. Inflamm Bowel Dis 2013;19:1789-1797.
4. Glaser S, Meng F, Han Y, Onori P, Chow BK, Francis H, et al. Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice. Gastroenterology 2014;146:1795-1808.e12.
5. Gaudio E, Barbaro B, Alvaro D, Glaser S, Francis H, Franchitto A, et al. Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats. Am J Physiol Gastrointet Liver Physiol 2006;291:G307-G317.
6. Gaudio E, Barbaro B, Alvaro D, Glaser S, Francis H, Ueno Y, et al. Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. Gastroenterology 2006;130:1270-1282.
7. Francis H, Franchitto A, Ueno Y, Glaser S, DeMorrow S, Venter J, et al. H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. Lab Invest 2007;87:473-487.
8. Francis H, Glaser S, Demorrow S, Gaudio E, Ueno Y, Venter J, et al. Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway. Am J Physiol Cell Physiol 2008;295:C499-C513.
9. 2+) and cAMP-dependent signaling mechanisms. Lab Invest 2012;92:282-294.
10. Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut 2015;64:830-841.
11. Penz-Osterreicher M, Osterreicher CH, Trauner M. Fibrosis in autoimmune and cholestatic liver disease. Best Pract Res Clin Gastroenterol 2011;25:245-258.
12. Omenetti A, Syn WK, Jung Y, Francis H, Porrello A, Witek RP, et al. Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. Hepatology 2009;50:518-527.
13. Omenetti A, Yang L, Gainetdinov RR, Guy CD, Choi SS, Chen W, et al. Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults. Am J Physiol Gastrointest Liver Physiol 2011;300:G303-G315.
14. Balta C, Herman H, Boldura OM, Gasca I, Rosu M, Ardelean A, Hermenean A. Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-beta/Smad signaling pathway. Chem Biol Interact 2015;240:94-101.
15. Ishii M, Iwai M, Harada Y, Morikawa T, Okanoue T, Kishikawa T, et al. A role of mast cells for hepatic fibrosis in primary sclerosing cholangitis. Hepatol Res 2005;31:127-131.
16. Bachelet I, Levi-Schaffer F, Mekori YA. Mast cells: not only in allergy. Immunol Allergy Clin North Am 2006;26:407-425.
17. Johnson C, Huynh V, Hargrove L, Kennedy L, Graf-Eaton A, Owens J, et al. Inhibition of mast cell-derived histamine decreases human cholangiocarcinoma growth and differentiation via c-Kit/stem cell factor-dependent signaling. Am J Pathol 2016;186:123-133.
18. Kennedy LL, Hargrove LA, Graf AB, Francis TC, Hodges KM, Nguyen QP, et al. Inhibition of mast cell-derived histamine secretion by cromolyn sodium treatment decreases biliary hyperplasia in cholestatic rodents. Lab Invest 2014;94:1406-1418.
19. –/– mice. Hepatology 2016;64:1202-1216.
20. Akiyoshi H, Terada T. Mast cell, myofibroblast and nerve terminal complexes in carbon tetrachloride-induced cirrhotic rat livers. J Hepatol 1998;29:112-119.
21. Halova I, Draberova L, Draber P. Mast cell chemotaxis—chemoattractants and signaling pathways. Front Immunol 2012;3:119.
22. Beaven MA. Our perception of the mast cell from Paul Ehrlich to now. Eur J Immunol 2009;39:11-25.
23. Boyce JA. The biology of the mast cell. Allergy Asthma Proc 2004;25:27-30.
24. Geissler EN, McFarland EC, Russell ES. Analysis of pleiotropism at the dominant white-spotting (W) locus of the house mouse: a description of ten new W alleles. Genetics 1981;97:337-361.
25. Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 2005;167:835-848.
26. Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 1978;52:447-452.
27. Niwa Y, Kasugai T, Ohno K, Morimoto M, Yamazaki M, Dohmae K, et al. Anemia and mast cell depletion in mutant rats that are homozygous at “white spotting (Ws)” locus. Blood 1991;78:1936-1941.
28. Francis H, DeMorrow S, Venter J, Onori P, White M, Gaudio E, et al. Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma. Gut 2012;61:753-764.
29. Graf A, Meng F, Hargrove L, Kennedy L, Han Y, Francis T, et al. Knockout of histidine decarboxylase decreases bile duct ligation-induced biliary hyperplasia via downregulation of the histidine decarboxylase/VEGF axis through PKA-ERK1/2 signaling. Am J Physiol Gastrointest Liver Physiol 2014;307:G813-G823.
30. Meng F, Onori P, Hargrove L, Han Y, Kennedy L, Graf A, et al. Regulation of the histamine/VEGF axis by miR-125b during cholestatic liver injury in mice. Am J Pathol 2014;184:662-673.
31. Melillo RM, Guarino V, Avilla E, Galdiero MR, Liotti F, Prevete N, et al. Mast cells have a protumorigenic role in human thyroid cancer. Oncogene 2010;29:6203-6215.
32. Cassiman D, van Pelt J, De Vos R, Van Lommel F, Desmet V, Yap SH, Roskams T. Synaptophysin: a novel marker for human and rat hepatic stellate cells. Am J Pathol 1999;155:1831-1839.
33. Xu B, Broome U, Uzunel M, Nava S, Ge X, Kumagai-Braesch M, et al. Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis. Am J Pathol 2003;163:1275-1289.
34. Niranjan R, Mavi P, Rayapudi M, Dynda S, Mishra A. Pathogenic role of mast cells in experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol 2013;304:G1087-G1094.
35. Smith DD, Tan X, Raveendran VV, Tawfik O, Stechschulte DJ, Dileepan KN. Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice. Am J Physiol Heart Circ Physiol 2012;302:H2612-H2621.
36. Miyazawa S, Hotta O, Doi N, Natori Y, Nishikawa K, Natori Y. Role of mast cells in the development of renal fibrosis: use of mast cell-deficient rats. Kidney Int 2004;65:2228-2237.
37. Hara M, Ono K, Hwang MW, Iwasaki A, Okada M, Nakatani K, et al. Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med 2002;195:375-381.
38. Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 2014;71:549-574.
39. Sugihara A, Tsujimura T, Fujita Y, Nakata Y, Terada N. Evaluation of role of mast cells in the development of liver fibrosis using mast cell-deficient rats and mice. J Hepatol 1999;30:859-867.
40. Veerappan A, O'Connor NJ, Brazin J, Reid AC, Jung A, McGee D, et al. Mast cells: a pivotal role in pulmonary fibrosis. DNA Cell Biol 2013;32:206-218.
41. Shao Z, Nazari M, Guo L, Li SH, Sun J, Liu SM, et al. The cardiac repair benefits of inflammation do not persist: evidence from mast cell implantation. J Cell Mol Med 2015;19:2751-2762.
42. Garcia-Roman J, Ibarra-Sanchez A, Lamas M, Gonzalez Espinosa C. VEGF secretion during hypoxia depends on free radicals-induced Fyn kinase activity in mast cells. Biochem Biophys Res Commun 2010;401:262-267.
43. Jimenez-Andrade GY, Ibarra-Sanchez A, Gonzalez D, Lamas M, Gonzalez-Espinosa C. Immunoglobulin E induces VEGF production in mast cells and potentiates their pro-tumorigenic actions through a Fyn kinase-dependent mechanism. J Hematol Oncol 2013;6:56.
44. Lilla JN, Werb Z. Mast cells contribute to the stromal microenvironment in mammary gland branching morphogenesis. Dev Biol 2010;337:124-133.
45. Marzioni M, Glaser S, Francis H, Marucci L, Benedetti A, Alvaro D, et al. Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. Gastroenterology 2005;128:121-137.
46. Ghosh AK, Hirasawa N, Ohtsu H, Watanabe T, Ohuchi K. Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J Exp Med 2002;195:973-982.
47. Wang Q, Zhao DY, Xu H, Zhou H, Yang QY, Liu F, Zhou GP. Down-regulation of microRNA-223 promotes degranulation via the PI3K/Akt pathway by targeting IGF-1R in mast cells. PLoS One 2015;10:e0123575.